241
PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PROOF OF CONCEPT STUDY OF EFFICACY OF RIFAMYCIN SV-MMX® 600 MG ADMINISTERED THREE OR TWO TIMES DAILY TO PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D)
Date
May 18, 2024
Tracks
Related Products
WHY DO REFLUX PATIENTS PRESS THE BUTTON? FACTORS CONTRIBUTING TO REAL-TIME ESOPHAGEAL SYMPTOM REPORTING IN REFRACTORY REFLUX PATIENTS
Introduction: Physiological and psychological factors contribute to gastroesophageal reflux symptoms. However, most research assesses reflux symptom severity via questionnaires…
PROSPECTIVE EVALUATION OF OPIOID WITHDRAWAL IN PATIENTS WITH SUSPECTED OPIOID-INDUCED ESOPHAGEAL DYSFUNCTION (OIED)
Opioid-induced esophageal dysfunction (OIED) is a recognized consequence of chronic opioid use, manifesting mainly as non-obstructive dysphagia and esophageal motility abnormalities documented in manometry studies including type III achalasia, hypercontractile esophagus, distal esophageal spasm, an…
COMBINED BODY SURFACE GASTRIC MAPPING AND GASTRIC EMPTYING TESTING REVEALS DISTINCT PATIENT SUBGROUPS IN GASTROPARESIS
BACKGROUND: Gastric emptying testing is used to diagnose gastroparesis. However, gastroparesis is a heterogeneous disorder that may involve several distinct underlying pathophysiologies related to impaired gastric function…
DUODENAL T CELL PROFILE PREDICTS RESPONSE TO HIGH-DOSE PROTON PUMP INHIBITORS IN FUNCTIONAL DYSPEPSIA
I: Functional dyspepsia (FD) is a chronic gastrointestinal (GI) disorder with incompletely understood pathophysiology…